NY A08664

Authorizes licensed pharmacists with a certificate of administration to administer FDA-approved reversible progestin-only contraceptive injections (such as Depo-Provera) pursuant to a valid patient-specific prescription

Requires pharmacists to notify the prescribing provider within five days of administering the injection, using electronic medical records, e-prescribing technology, fax, or telephone

Mandates that pharmacists receive training approved by the Commissioner of Education and Commissioner of Health covering screening, informed consent, administration techniques, contraindications, record keeping, and emergency handling including anaphylaxis

Prohibits pharmacy-based administration until after the patient has received their initial injection from a prescriber and is deemed eligible for maintenance treatment

Takes effect 180 days after becoming law, with immediate authorization for regulatory agencies to develop implementing rules